Adoption of a resolution by the Company's Management Board on the issue of shares as part of an authorised share capital increase. podwyższenia kapitału zakładowego

Current report no. 36/2024

Date of preparation: 20 November 2024

Subject: Adoption of a resolution by the Company's Management Board on the issue of shares as part of an authorised share capital increase.

Legal basis: Article 56(1)(2) of the Act on Offering - current information.                                                                                                                   

The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the ‘Company’) announces that on 20 November 2024, the Company's Management Board adopted a resolution on the issue of not less than 1 (one) but not more than 822,467 (eight hundred and twenty-two thousand four hundred and sixty-seven) series T ordinary bearer shares, within the limits of the Company's authorised capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.

The share issue is related to the commencement of the book-building process for the offering of new series T bearer shares and the conclusion of the share offering placement agreement, of which the Company informed in current report No. 35/2024 of 20 November 2024.

The Company provides the text of the adopted resolution as an attachment.

tej uchwały.